Mats Anders Nilsson
Vorstandsvorsitzender bei KARESSA PHARMA HOLDING AB (PUBL)
Aktive Positionen von Mats Anders Nilsson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KARESSA PHARMA HOLDING AB (PUBL) | Vorstandsvorsitzender | 01.01.2018 | - |
| Investor Relations Kontakt | 01.01.2018 | - | |
| Public Communications Contact | 01.01.2018 | - |
Karriereverlauf von Mats Anders Nilsson
Statistik
International
| Schweden | 2 |
Operativ
| Chief Executive Officer | 1 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Karessa Pharma Holding AB
 Karessa Pharma Holding AB Pharmaceuticals: MajorHealth Technology Karessa Pharma Holding AB engages in the development and commercialization of products in the therapeutic area of erectile dysfunction. Its patented drug is an alignate-based polymer film that is applied to the oral mucosa, which then rapidly delivered out into the bloodstream. The company was founded by Fredrik Hubinette on September 11, 2013 and is headquartered in Taby, Sweden. | Health Technology |
- Börse
- Insiders
- Mats Anders Nilsson
- Erfahrung
